Insights into how adeno-squamous transition drives KRAS inhibitor resistance

Feng Hu,Piro Lito
DOI: https://doi.org/10.1016/j.ccell.2024.02.014
IF: 50.3
2024-03-12
Cancer Cell
Abstract:The histologic transformation of adenocarcinoma (ADC) to squamous cell carcinoma (SCC), known as adeno-squamous transition or AST, is frequently observed in patients with lung cancer undergoing cancer therapy. In this issue, Tong and colleagues investigate genetic and epigenetic mechanisms that drive AST to confer resistance to KRAS inhibitors in preclinical models and patients.
oncology,cell biology
What problem does this paper attempt to address?